Let's clear the way for CDS


Wary of overly restrictive regulation, the derivatives industry is driving measures to improve the transparency and clearing of OTC instruments. But will its efforts be enough?

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree